Korean Diabetes J.  2008 Apr;32(2):173-174. 10.4093/kdj.2008.32.2.173.

The Plasma Adiponectin Levels in Patients with Newly Diagnosed Type 2 Diabetes

• Lee IS
• Ku BJ
• Kim YK

• KMID: 2222515
• DOI: http://doi.org/10.4093/kdj.2008.32.2.173

Abstract

No abstract available.

MeSH Terms

Adiponectin
Humans
Plasma
Adiponectin

Reference

2. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev. 2005. 26:439–451.

3. Abbasi F, Chang SA, Chu JW, Ciaraldi TP, Lamendola C, McLaughlin T, Reaven GM, Reaven PD. Improvements in insulin resistance with weight loss, in contrast to rosiglitazone, are not associated with changes in plasma adiponectin or adiponectin multimeric complexes. Am J Physiol Regul Integr Comp Physiol. 2006. 290:R139–R144.

4. Martin M, Palaniappan LP, Kwan AC, Reaven GM, Reaven PD. Ethnic differences in the relationship between adiponectin and insulin sensitivity in South Asian and Caucasian women. Diabetes Care. 2008. 31:798–801.

6. Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H, Imai Y, Nagai R, Kadowaki T. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care. 2006. 29:1357–1362.